| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |